Filing Details

Accession Number:
0000109657-11-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-19 20:34:32
Reporting Period:
2010-12-23
Filing Date:
2011-01-19
Accepted Time:
2011-01-19 20:34:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
109657 Oxis International Inc OXIS.OB Pharmaceutical Preparations (2834) 941620407
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223658 Anshuman Dube 2049 Century Park East
Suite 3630
Los Angeles CA 90067
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-23 700,000 $0.05 700,000 No 4 C Indirect Theorem Group, LLC
Common Stock Disposition 2010-12-23 339,900 $0.13 360,100 No 4 S Indirect Theorem Group, LLC
Common Stock Disposition 2010-12-27 360,100 $0.13 0 No 4 S Indirect Theorem Group, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Theorem Group, LLC
No 4 S Indirect Theorem Group, LLC
No 4 S Indirect Theorem Group, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 0% Convertible Debenture Disposition 2010-12-23 700,000 $0.05 700,000 $0.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,100,000 2009-10-01 2011-09-30 No 4 C Indirect
Footnotes
  1. Sale of common stock acquired through partial conversion of underlying debenture.
  2. The reporting person is a managing director of Theorem Group, LLC. The reporting person disclaims beneficial ownership of the securities held by Theorem Group, LLC, except to the extent of his pecuniary interest therein.